ME Therapeutics Holdings Inc.
METX
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.29% | 46.30% | -14.65% | -8.54% | 22.15% |
| Total Receivables | 44.97% | -11.05% | 54.47% | 28.13% | 62.71% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -45.73% | -29.90% | 221.93% | 648.00% | -57.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.67% | 40.75% | -10.02% | -6.92% | 21.92% |
|
|
|||||
| Total Current Assets | -10.67% | 40.75% | -10.02% | -6.92% | 21.92% |
| Net Property, Plant & Equipment | -2.41% | 113.16% | 79,700.00% | 0.00% | 0.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.33% | -3.85% | -- | -- | -- |
| Total Assets | -9.74% | 45.64% | -2.34% | -6.91% | 21.92% |
|
|
|||||
| Total Accounts Payable | 484.21% | -91.15% | 88.30% | 238.61% | -- |
| Total Accrued Expenses | -28.62% | 17.47% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.59% | 1.31% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 359.26% | -- |
| Total Other Current Liabilities | -- | -- | -- | 359.26% | -- |
| Total Current Liabilities | 47.97% | -43.14% | 169.10% | 35.86% | -- |
|
|
|||||
| Total Current Liabilities | 47.97% | -43.14% | 169.10% | 35.86% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -33.33% | -28.29% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.23% | -39.48% | 257.08% | 35.86% | -- |
|
|
|||||
| Common Stock & APIC | 4.91% | 36.45% | -3.68% | 1.10% | 33.42% |
| Retained Earnings | -9.01% | 0.72% | 0.28% | -4.94% | -5.86% |
| Treasury Stock & Other | 4.91% | -36.70% | 0.09% | 5.53% | -18.03% |
| Total Common Equity | -11.99% | 60.60% | -13.40% | -8.15% | 18.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.99% | 60.60% | -13.40% | -8.15% | 18.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.99% | 60.60% | -13.40% | -8.15% | 18.50% |
|
|
|||||